comparemela.com

Latest Breaking News On - Nektar therapeutics - Page 11 : comparemela.com

Nektar Therapeutics (NASDAQ:NKTR) Coverage Initiated by Analysts at StockNews com

StockNews.com began coverage on shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) in a research note published on Thursday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Several other brokerages have also recently issued reports on NKTR. JPMorgan Chase & Co. reiterated an underweight rating on shares of Nektar Therapeutics in […]

United statesVanguard group incInvesco ltdNektar therapeuticsJpmorgan chase coBlackrock incFree reportGet free reportDeep track capitalTrack capitalNektar therapeutics dailyNasdaq nktrInitiated coverageStocknews com

Following a 75% decline over last year, recent gains may please Nektar Therapeutics (NASDAQ:NKTR) institutional owners

Key Insights Given the large stake in the stock by institutions, Nektar Therapeutics' stock price might be vulnerable.

Nektar therapeuticsNektar therapeuticNstitutional ownershipInstitutional investorsNsider ownershipHare registry

Inspire Medical names Intuitive Surgical CMO to board (NYSE:INSP)

Inspire Medical names Intuitive Surgical CMO to board (NYSE:INSP)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Myriam curetExecutive boardInspire medical systemsIntuitive surgicalChief medical officerNektar therapeutics

Chimerix (CMRX) Appoints Lisa Decker to its Board

Chimerix (CMRX) Appoints Lisa Decker to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Lisa deckerMike andrioleBusiness developmentOffice of technology managementUniversity of massachusetts medical schoolAtreca incTufts university school of medicineNektar therapeuticsCollege of the holy crossChief business officerCatherine gilliss phdChimerix boardChief executive officerVice presidentAssociate directorTechnology management

Chimerix Appoints Lisa Decker to Board of Directors

DURHAM, N.C., Dec. 29, 2023 (GLOBE NEWSWIRE) Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly

Mike andrioleLisa deckerUniversity of massachusetts medical schoolCollege of the holy crossOffice of technology managementBusiness developmentTufts university school of medicineAtreca incNektar therapeuticsChief business officerCatherine gilliss phdChimerix boardChief executive officerVice presidentAssociate directorTechnology management

vimarsana © 2020. All Rights Reserved.